WHITEGLOVE HEALTH, INC. INDEPENDENT NON-EMPLOYEE DIRECTOR STOCK ISSUANCE AGREEMENTStock Issuance Agreement • June 6th, 2011 • Whiteglove House Call Health Inc • Services-health services • Delaware
Contract Type FiledJune 6th, 2011 Company Industry JurisdictionAGREEMENT made as of this day of , 20 by and between WhiteGlove Health, Inc., a Delaware corporation (the “Company”), and , Participant in the Company’s 2011 Equity Incentive Plan (“Participant”).
WHITEGLOVE HOUSE CALL HEALTH, INC. 2,500,000 Shares of Common Stock $0.0001 par value per share UNDERWRITING AGREEMENTUnderwriting Agreement • June 6th, 2011 • Whiteglove House Call Health Inc • Services-health services • New York
Contract Type FiledJune 6th, 2011 Company Industry JurisdictionWhiteGlove House Call Health, Inc., a Delaware corporation (the “Company”), proposes to issue and sell up to an aggregate of 2,500,000 shares of common stock (the “Firm Shares”), par value $0.0001 per share (the “Common Stock”), to investors (collectively, the “Investors”) in a public offering. The stockholders of the Company named in Schedule II attached hereto (the “Selling Stockholders”) propose, severally and not jointly and subject to the terms and conditions stated herein, to grant to the Underwriters an option to purchase up to an aggregate of 375,000 shares of Common Stock (the “Over-allotment Option” and such shares, the “Option Shares”). The Firm Shares and Option Shares are herein called the “Shares.” The Company desires to engage you as Underwriters (the “Underwriters”) in connection with such issuance and sale of the Firm Shares. The Shares are more fully described in the Registration Statement (as hereinafter defined).
EMPLOYMENT AGREEMENTEmployment Agreement • June 6th, 2011 • Whiteglove House Call Health Inc • Services-health services • Texas
Contract Type FiledJune 6th, 2011 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into as of April 26, 2007, by and between WHlTEGLOVE HOUSE CALL HEALTH, Inc., a Texas corporation (the “Company”), and Robert A. Fabbio, an individual (the “Executive”).